References
- BernardHU , BurkRD , ChenZ , van DoorslaerK , zur HausenH , de VilliersEM. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology401(1), 70–79 (2010).
- BravoIG , de SanjoseS , GottschlingM. The clinical importance of understanding the evolution of papillomaviruses. Trends Microbiol.18(10), 432–438 (2010).
- WoodmanCB , CollinsSI , YoungLS. The natural history of cervical HPV infection: unresolved issues. Nat. Rev. Cancer7(1), 11–22 (2007).
- TommasinoM. The human papillomavirus family and its role in carcinogenesis. Semin. Cancer Biol.26, 13–21 (2014).
- DoorbarJ , EgawaN , GriffinH , KranjecC , MurakamiI. Human papillomavirus molecular biology and disease association. Rev. Med. Virol.25(Suppl. 1), 2–23 (2015).
- Van DoorslaerK. Evolution of the papillomaviridae. Virology445(1–2), 11–20 (2013).
- de VilliersEM , FauquetC , BrokerTR , BernardHU , zur HausenH. Classification of papillomaviruses. Virology324(1), 17–27 (2004).
- McLaughlin-DrubinME , MeyersJ , MungerK. Cancer associated human papillomaviruses. Curr. Opin. Virol.2(4), 459–466 (2012).
- MistryN , WibomC , EvanderM. Cutaneous and mucosal human papillomaviruses differ in net surface charge, potential impact on tropism. Virol. J.5, 118 (2008).
- GormleyRH , KovarikCL. Human papillomavirus-related genital disease in the immunocompromised host: Part I. J. Am. Acad. Dermatol.66(6), Doi: 10.1016/j.jaad.2010.12.049 (2012).
- GillisonML , ChaturvediAK , AndersonWF , FakhryC. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J. Clin. Oncol.33(29), 3235–3242 (2015).
- Cancer Genome Atlas Research N, Albert Einstein College of M, Analytical Biological Set al.Integrated genomic and molecular characterization of cervical cancer. Nature543(7645), 378–384 (2017).
- ZhaoX , ZhuW , ZhangRet al.Targeted juglone blocks the invasion and metastasis of HPV-positive cervical cancer cells. J. Pharmaco. Sci.140(3), 211–217 (2019).
- BottalicoD , ChenZ , DunneAet al.The oral cavity contains abundant known and novel human papillomaviruses from the betapapillomavirus and gammapapillomavirus genera. J. Infect. Dis.204(5), 787–792 (2011).
- AccardiR , GheitT. Cutaneous HPV and skin cancer. Presse Med.43(12 Pt 2), e435–443 (2014).
- PyeonD , PearceSM , LankSM , AhlquistP , LambertPF. Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathogens5(2), e1000318 (2009).
- WestrichJA , WarrenCJ , PyeonD. Evasion of host immune defenses by human papillomavirus. Virus Res.231, 21–33 (2017).
- UnterholznerL , KeatingSE , BaranMet al.IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol.11(11), 997–1004 (2010).
- MoodyC. Mechanisms by which HPV induces a replication competent environment in differentiating keratinocytes. Viruses9(9), 261 (2017).
- DaSilva DM , WoodhamAW , SkeateJGet al.Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C. Clin. Immunol.161(2), 197–208 (2015).
- KosterMI , RoopDR. Mechanisms regulating epithelial stratification. Ann. Rev. Cell Dev. Biol.23, 93–113 (2007).
- EgawaN , EgawaK , GriffinH , DoorbarJ. Human papillomaviruses; epithelial tropisms, and the development of neoplasia. Viruses7(7), 3863–3890 (2015).
- ZhengZM , BakerCC. Papillomavirus genome structure, expression, and post-transcriptional regulation. Front. Biosci.11, 2286–2302 (2006).
- GrahamSV. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review. Clin. Sci. (Lond).131(17), 2201–2221 (2017).
- EspinosaI , LeeCH , KimMKet al.A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Am. J. Surg. Pathol.32(2), 210–218 (2008).
- Yeo-TehNSL , ItoY , JhaS. High-risk human papillomaviral oncogenes E6 and E7 target key cellular pathways to achieve oncogenesis. Int. J. Mol. Sci.19(6), 1706 (2018).
- GrahamSV. Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies. Future Microbiol.5(10), 1493–1506 (2010).
- VonskyM , ShabaevaM , RunovAet al.Carcinogenesis associated with human papillomavirus infection. mechanisms and potential for immunotherapy. Biochemistry (Mosc).84(7), 782–799 (2019).
- MesriEA , FeitelsonMA , MungerK. Human viral oncogenesis: a cancer hallmarks analysis. Cell Host Microbe15(3), 266–282 (2014).
- Hoppe-SeylerK , BosslerF , BraunJA , HerrmannAL , Hoppe-SeylerF. The HPV E6/E7 oncogenes: key factors for viral carcinogenesis and therapeutic targets. Trends Microbiol.26(2), 158–168 (2018).
- HanahanD , WeinbergRA. Hallmarks of cancer: the next generation. Cell144(5), 646–674 (2011).
- Ruttkay-NedeckyB , JimenezJimenez AM , NejdlLet al.Relevance of infection with human papillomavirus: the role of the p53 tumor suppressor protein and E6/E7 zinc finger proteins (Review). Int. J. Oncol.43(6), 1754–1762 (2013).
- CohenSB , GrahamME , LovreczGO , BacheN , RobinsonPJ , ReddelRR. Protein composition of catalytically active human telomerase from immortal cells. Science315(5820), 1850–1853 (2007).
- CampanellaNC , CelestinoR , PestanaAet al.Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs). Eur. J. Hum. Genet.23(6), 877–879 (2015).
- CampanellaNC , PennaV , Abrahao-MachadoLFet al.TERT promoter mutations in soft tissue sarcomas. Int.J. Biol. Markers31(1), e62–e67 (2016).
- Van DoorslaerK , BurkRD. Association between hTERT activation by HPV E6 proteins and oncogenic risk. Virology433(1), 216–219 (2012).
- HeidenreichB , RachakondaPS , HemminkiK , KumarR. TERT promoter mutations in cancer development. Curr. Opin. Genetics Dev.24, 30–37 (2014).
- FerlayJ , SoerjomataramI , DikshitRet al.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer136(5), E359–E386 (2015).
- MartinCM , O’LearyJJ. Histology of cervical intraepithelial neoplasia and the role of biomarkers. Best Pract. Res. Clin. Obstet. Gynaecol.25(5), 605–615 (2011).
- PimpleS , MishraG , ShastriS. Global strategies for cervical cancer prevention. Curr. Opin. Obstet. Gynecol.28(1), 4–10 (2016).
- SignorelliC , OdoneA , CiorbaVet al.Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence. Epidemiol. Infect.145(10), 1962–1982 (2017).
- BondeJ , EjegodDM , CuschieriKet al.The Valgent4 protocol: robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath medium. J. Clin. Virol.108, 64–71 (2018).
- GradissimoA , BurkRD. Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention. Expert Rev. Mol. Diagn.17(4), 379–391 (2017).
- WHO Guidelines. Early diagnosis and screening. Important guide to the prevention of cervical cancer worldwide (2019). www.who.int/cancer/prevention/diagnosis-screening/cervical-cancer/en/
- RaoR , MolinaD , HalliganAM , VakilB , AlpersteinSA , HodaRS. Negative computer-imaged ThinPrep pap test and positive hybrid capture2 HPV co-testing results: a quality assurance review. Diagn. Cytopathol.43(9), 763–769 (2015).
- MorrisBJ. The advent of human papillomavirus detection for cervical screening. Curr. Opin. Obstet. Gynecol.31(5), 333–339 (2019).
- ROCHE. Roche Molecular Systems. (2019). https://diagnostics.roche.com/us/en/products/params/cobas-hpv.html
- LeeDH , HwangNR , LimMCet al.Comparison of the performance of Anyplex II HPV HR, the Cobas 4800 human papillomavirus test and Hybrid Capture 2. Ann. Clin. Biochem.53(Pt 5), 561–567 (2016).
- de ThurahL , BondeJ , LamJUH , ReboljM. Concordant testing results between various human papillomavirus assays in primary cervical cancer screening: systematic review. Clin. Microbiol. Infection24(1), 29–36 (2018).
- GalatiL , EquestreM , BruniRet al.Identification of human papillomavirus type 16 variants circulating in the Calabria region by sequencing and phylogenetic analysis of HPV16 from cervical smears. Infect. Genet. Evol.68, 185–193 (2019).
- AgalliuI , GapsturS , ChenZet al.Associations of oral alpha-, beta-, and gamma-human papillomavirus types with risk of incident head and neck cancer. JAMA Oncol.2(5), 599–606 (2016).
- ArroyoLS , SmelovV , BzhalavaD , EklundC , HultinE , DillnerJ. Next generation sequencing for human papillomavirus genotyping. J. Clin. Virol.58(2), 437–442 (2013).
- MirabelloL , YeagerM , CullenMet al.HPV16 sublineage associations with histology-specific cancer risk using HPV whole-genome sequences in 3200 women. J. Natl Cancer Inst.108(9), 100 (2016).
- TeixeiraJC , ValeDB , BragancaJF , CamposCS , DiscacciatiMG , ZeferinoLC. Cervical cancer screening program based on primary DNA-HPV testing in a Brazilian city: a cost–effectiveness study protocol. BMC Public Health20(1), 576 (2020).